Integra Lifesciences Holdings (IART) Revenue Growth (1y) (2010 - 2026)
Integra Lifesciences Holdings (IART) Revenue Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 16.70% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 15.05% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 7.41% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 6.08% |
| 10 | Integra Lifesciences Holdings | 1.50 Bn | 1.23 Bn | 216.98 Mn | 2.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.42% |
| Dec 31, 2025 | -1.74% |
| Sep 30, 2025 | 5.57% |
| Jun 30, 2025 | -0.61% |
| Mar 31, 2025 | 3.74% |
| Dec 31, 2024 | 11.49% |
| Sep 30, 2024 | -0.41% |
| Jun 30, 2024 | 9.68% |
| Mar 31, 2024 | -3.14% |
| Dec 31, 2023 | -0.25% |
| Sep 30, 2023 | -0.72% |
| Jun 30, 2023 | -4.16% |
| Mar 31, 2023 | 1.12% |
| Dec 31, 2022 | -1.85% |
| Sep 30, 2022 | -0.43% |
| Jun 30, 2022 | 2.01% |
| Mar 31, 2022 | 4.60% |
| Dec 31, 2021 | 4.34% |
| Sep 30, 2021 | 4.49% |
| Jun 30, 2021 | 50.77% |